aluates Reports

$ 0.0

Automative

Global Bioactive Protein and Peptides Market Research Report 2026

Published Date: 2026-04-23

Report Code: QYRE-Auto-23Q7577

Global Bioactive Protein and Peptides Market Insights and Forecast to 2028

BUY CHAPTERS

Global Bioactive Protein and Peptides Market Research Report 2026

Code: QYRE-Auto-23Q7577

Report

2026-04-23

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Kerry Group

Bunge

Gelita

Vital Proteins

Rousselot

BRF Ingredients

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Seagarden

Baotou Dongbao Bio-tech

Morinaga Milk

Nuritas

SmartPEP

Hubei Reborn Biotech

Shandong Hengxin Biotech

Wuhan Jiushengtang Biotech

Collagile

Bioactive Protein and Peptides Market Size

The global Bioactive Protein and Peptides market was valued at US$ 2044 million in 2025 and is anticipated to reach US$ 3244 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Bioactive Protein and Peptides Market

Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.

Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

This report delivers a comprehensive overview of the global Bioactive Protein and Peptides market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bioactive Protein and Peptides. The Bioactive Protein and Peptides market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Bioactive Protein and Peptides market comprehensively. Regional market sizes by Source, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Bioactive Protein and Peptides manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Source, by Application, and by region.

Market Segmentation

Scope of Bioactive Protein and Peptides Market Report

Report Metric	Details
Report Name	Bioactive Protein and Peptides Market
Accounted market size in 2025	US$ 2044 million
Forecasted market size in 2032	US$ 3244 million
CAGR	6.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Source	Plant Source Animal Source
Segment by Application	Functional Food Dietary Supplements Personal Care Animal Nutrition Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, Bunge Ltd, Ingredia Nutritional, Gelatines Weishardt, PanTheryx, Hubei Reborn Biotech, Seagarden, Shandong Hengxin Biotech, Baotou Dongbao Bio-Tech, Wuhan Jiushengtang Biotech, Morinaga Milk, Collagile, Nuritas, SmartPEP
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Source, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Bioactive Protein and Peptides companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Source, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Bioactive Protein and Peptides Market growing?

Ans: The Bioactive Protein and Peptides Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Bioactive Protein and Peptides Market size in 2032?

Ans: The Bioactive Protein and Peptides Market size in 2032 will be US$ 3244 million.

What is the market share of major companies in Bioactive Protein and Peptides Market?

Ans: The top five players hold a share over 50%.

What is the Bioactive Protein and Peptides Market share by region?

Ans: North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

Who are the main players in the Bioactive Protein and Peptides Market report?

Ans: The main players in the Bioactive Protein and Peptides Market are Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, Bunge Ltd, Ingredia Nutritional, Gelatines Weishardt, PanTheryx, Hubei Reborn Biotech, Seagarden, Shandong Hengxin Biotech, Baotou Dongbao Bio-Tech, Wuhan Jiushengtang Biotech, Morinaga Milk, Collagile, Nuritas, SmartPEP

What are the Application segmentation covered in the Bioactive Protein and Peptides Market report?

Ans: The Applications covered in the Bioactive Protein and Peptides Market report are Functional Food, Dietary Supplements, Personal Care, Animal Nutrition, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Source

1.2.1 Global Bioactive Protein and Peptides Market Size Growth Rate by Source: 2021 vs 2025 vs 2032

1.2.2 Plant Source

1.2.3 Animal Source

1.3 Market by Application

1.3.1 Global Bioactive Protein and Peptides Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Functional Food

1.3.3 Dietary Supplements

1.3.4 Personal Care

1.3.5 Animal Nutrition

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bioactive Protein and Peptides Market Perspective (2021–2032)

2.2 Global Bioactive Protein and Peptides Growth Trends by Region

2.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Bioactive Protein and Peptides Historic Market Size by Region (2021–2026)

2.2.3 Bioactive Protein and Peptides Forecasted Market Size by Region (2027–2032)

2.3 Bioactive Protein and Peptides Market Dynamics

2.3.1 Bioactive Protein and Peptides Industry Trends

2.3.2 Bioactive Protein and Peptides Market Drivers

2.3.3 Bioactive Protein and Peptides Market Challenges

2.3.4 Bioactive Protein and Peptides Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bioactive Protein and Peptides Players by Revenue

3.1.1 Global Top Bioactive Protein and Peptides Players by Revenue (2021–2026)

3.1.2 Global Bioactive Protein and Peptides Revenue Market Share by Players (2021–2026)

3.2 Global Top Bioactive Protein and Peptides Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Bioactive Protein and Peptides Revenue

3.4 Global Bioactive Protein and Peptides Market Concentration Ratio

3.4.1 Global Bioactive Protein and Peptides Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bioactive Protein and Peptides Revenue in 2025

3.5 Global Key Players of Bioactive Protein and Peptides Head Offices and Areas Served

3.6 Global Key Players of Bioactive Protein and Peptides, Products and Applications

3.7 Global Key Players of Bioactive Protein and Peptides, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Bioactive Protein and Peptides Breakdown Data by Source

4.1 Global Bioactive Protein and Peptides Historic Market Size by Source (2021–2026)

4.2 Global Bioactive Protein and Peptides Forecasted Market Size by Source (2027–2032)

5 Bioactive Protein and Peptides Breakdown Data by Application

5.1 Global Bioactive Protein and Peptides Historic Market Size by Application (2021–2026)

5.2 Global Bioactive Protein and Peptides Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Bioactive Protein and Peptides Market Size (2021–2032)

6.2 North America Bioactive Protein and Peptides Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Bioactive Protein and Peptides Market Size by Country (2021–2026)

6.4 North America Bioactive Protein and Peptides Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bioactive Protein and Peptides Market Size (2021–2032)

7.2 Europe Bioactive Protein and Peptides Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Bioactive Protein and Peptides Market Size by Country (2021–2026)

7.4 Europe Bioactive Protein and Peptides Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Bioactive Protein and Peptides Market Size (2021–2032)

8.2 Asia-Pacific Bioactive Protein and Peptides Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2021–2026)

8.4 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Bioactive Protein and Peptides Market Size (2021–2032)

9.2 Latin America Bioactive Protein and Peptides Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Bioactive Protein and Peptides Market Size by Country (2021–2026)

9.4 Latin America Bioactive Protein and Peptides Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bioactive Protein and Peptides Market Size (2021–2032)

10.2 Middle East & Africa Bioactive Protein and Peptides Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2021–2026)

10.4 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gelita

11.1.1 Gelita Company Details

11.1.2 Gelita Business Overview

11.1.3 Gelita Bioactive Protein and Peptides Introduction

11.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.1.5 Gelita Recent Development

11.2 Kerry Group

11.2.1 Kerry Group Company Details

11.2.2 Kerry Group Business Overview

11.2.3 Kerry Group Bioactive Protein and Peptides Introduction

11.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.2.5 Kerry Group Recent Development

11.3 Vital Proteins

11.3.1 Vital Proteins Company Details

11.3.2 Vital Proteins Business Overview

11.3.3 Vital Proteins Bioactive Protein and Peptides Introduction

11.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.3.5 Vital Proteins Recent Development

11.4 Rousselot

11.4.1 Rousselot Company Details

11.4.2 Rousselot Business Overview

11.4.3 Rousselot Bioactive Protein and Peptides Introduction

11.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.4.5 Rousselot Recent Development

11.5 BRF Ingredients

11.5.1 BRF Ingredients Company Details

11.5.2 BRF Ingredients Business Overview

11.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction

11.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.5.5 BRF Ingredients Recent Development

11.6 Bunge Ltd

11.6.1 Bunge Ltd Company Details

11.6.2 Bunge Ltd Business Overview

11.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction

11.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.6.5 Bunge Ltd Recent Development

11.7 Ingredia Nutritional

11.7.1 Ingredia Nutritional Company Details

11.7.2 Ingredia Nutritional Business Overview

11.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction

11.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.7.5 Ingredia Nutritional Recent Development

11.8 Gelatines Weishardt

11.8.1 Gelatines Weishardt Company Details

11.8.2 Gelatines Weishardt Business Overview

11.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction

11.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.8.5 Gelatines Weishardt Recent Development

11.9 PanTheryx

11.9.1 PanTheryx Company Details

11.9.2 PanTheryx Business Overview

11.9.3 PanTheryx Bioactive Protein and Peptides Introduction

11.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.9.5 PanTheryx Recent Development

11.10 Hubei Reborn Biotech

11.10.1 Hubei Reborn Biotech Company Details

11.10.2 Hubei Reborn Biotech Business Overview

11.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction

11.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.10.5 Hubei Reborn Biotech Recent Development

11.11 Seagarden

11.11.1 Seagarden Company Details

11.11.2 Seagarden Business Overview

11.11.3 Seagarden Bioactive Protein and Peptides Introduction

11.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.11.5 Seagarden Recent Development

11.12 Shandong Hengxin Biotech

11.12.1 Shandong Hengxin Biotech Company Details

11.12.2 Shandong Hengxin Biotech Business Overview

11.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction

11.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.12.5 Shandong Hengxin Biotech Recent Development

11.13 Baotou Dongbao Bio-Tech

11.13.1 Baotou Dongbao Bio-Tech Company Details

11.13.2 Baotou Dongbao Bio-Tech Business Overview

11.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction

11.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.13.5 Baotou Dongbao Bio-Tech Recent Development

11.14 Wuhan Jiushengtang Biotech

11.14.1 Wuhan Jiushengtang Biotech Company Details

11.14.2 Wuhan Jiushengtang Biotech Business Overview

11.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction

11.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.14.5 Wuhan Jiushengtang Biotech Recent Development

11.15 Morinaga Milk

11.15.1 Morinaga Milk Company Details

11.15.2 Morinaga Milk Business Overview

11.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction

11.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.15.5 Morinaga Milk Recent Development

11.16 Collagile

11.16.1 Collagile Company Details

11.16.2 Collagile Business Overview

11.16.3 Collagile Bioactive Protein and Peptides Introduction

11.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.16.5 Collagile Recent Development

11.17 Nuritas

11.17.1 Nuritas Company Details

11.17.2 Nuritas Business Overview

11.17.3 Nuritas Bioactive Protein and Peptides Introduction

11.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.17.5 Nuritas Recent Development

11.18 SmartPEP

11.18.1 SmartPEP Company Details

11.18.2 SmartPEP Business Overview

11.18.3 SmartPEP Bioactive Protein and Peptides Introduction

11.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2021–2026)

11.18.5 SmartPEP Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kerry Group

Bunge

Gelita

Vital Proteins

Rousselot

BRF Ingredients

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Seagarden

Baotou Dongbao Bio-tech

Morinaga Milk

Nuritas

SmartPEP

Hubei Reborn Biotech

Shandong Hengxin Biotech

Wuhan Jiushengtang Biotech

Collagile

List of Tables

Table 1. Global Bioactive Protein and Peptides Market Size Growth Rate by Source (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Plant Source

Table 3. Key Players of Animal Source

Table 4. Global Bioactive Protein and Peptides Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Bioactive Protein and Peptides Market Size by Region (US$ Million), 2021–2026

Table 7. Global Bioactive Protein and Peptides Market Share by Region (2021–2026)

Table 8. Global Bioactive Protein and Peptides Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Bioactive Protein and Peptides Market Share by Region (2027–2032)

Table 10. Bioactive Protein and Peptides Market Trends

Table 11. Bioactive Protein and Peptides Market Drivers

Table 12. Bioactive Protein and Peptides Market Challenges

Table 13. Bioactive Protein and Peptides Market Restraints

Table 14. Global Bioactive Protein and Peptides Revenue by Players (US$ Million), 2021–2026

Table 15. Global Bioactive Protein and Peptides Market Share by Players (2021–2026)

Table 16. Global Top Bioactive Protein and Peptides Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bioactive Protein and Peptides Revenue, 2025

Table 17. Ranking of Global Top Bioactive Protein and Peptides Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Bioactive Protein and Peptides Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Bioactive Protein and Peptides, Headquarters and Area Served

Table 20. Global Key Players of Bioactive Protein and Peptides, Products and Applications

Table 21. Global Key Players of Bioactive Protein and Peptides, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Bioactive Protein and Peptides Market Size by Source (US$ Million), 2021–2026

Table 24. Global Bioactive Protein and Peptides Revenue Market Share by Source (2021–2026)

Table 25. Global Bioactive Protein and Peptides Forecasted Market Size by Source (US$ Million), 2027–2032

Table 26. Global Bioactive Protein and Peptides Revenue Market Share by Source (2027–2032)

Table 27. Global Bioactive Protein and Peptides Market Size by Application (US$ Million), 2021–2026

Table 28. Global Bioactive Protein and Peptides Revenue Market Share by Application (2021–2026)

Table 29. Global Bioactive Protein and Peptides Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Bioactive Protein and Peptides Revenue Market Share by Application (2027–2032)

Table 31. North America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Bioactive Protein and Peptides Market Size by Country (US$ Million), 2021–2026

Table 33. North America Bioactive Protein and Peptides Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Bioactive Protein and Peptides Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Bioactive Protein and Peptides Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Bioactive Protein and Peptides Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Bioactive Protein and Peptides Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Bioactive Protein and Peptides Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (US$ Million), 2027–2032

Table 46. Gelita Company Details

Table 47. Gelita Business Overview

Table 48. Gelita Bioactive Protein and Peptides Product

Table 49. Gelita Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 50. Gelita Recent Development

Table 51. Kerry Group Company Details

Table 52. Kerry Group Business Overview

Table 53. Kerry Group Bioactive Protein and Peptides Product

Table 54. Kerry Group Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 55. Kerry Group Recent Development

Table 56. Vital Proteins Company Details

Table 57. Vital Proteins Business Overview

Table 58. Vital Proteins Bioactive Protein and Peptides Product

Table 59. Vital Proteins Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 60. Vital Proteins Recent Development

Table 61. Rousselot Company Details

Table 62. Rousselot Business Overview

Table 63. Rousselot Bioactive Protein and Peptides Product

Table 64. Rousselot Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 65. Rousselot Recent Development

Table 66. BRF Ingredients Company Details

Table 67. BRF Ingredients Business Overview

Table 68. BRF Ingredients Bioactive Protein and Peptides Product

Table 69. BRF Ingredients Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 70. BRF Ingredients Recent Development

Table 71. Bunge Ltd Company Details

Table 72. Bunge Ltd Business Overview

Table 73. Bunge Ltd Bioactive Protein and Peptides Product

Table 74. Bunge Ltd Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 75. Bunge Ltd Recent Development

Table 76. Ingredia Nutritional Company Details

Table 77. Ingredia Nutritional Business Overview

Table 78. Ingredia Nutritional Bioactive Protein and Peptides Product

Table 79. Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 80. Ingredia Nutritional Recent Development

Table 81. Gelatines Weishardt Company Details

Table 82. Gelatines Weishardt Business Overview

Table 83. Gelatines Weishardt Bioactive Protein and Peptides Product

Table 84. Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 85. Gelatines Weishardt Recent Development

Table 86. PanTheryx Company Details

Table 87. PanTheryx Business Overview

Table 88. PanTheryx Bioactive Protein and Peptides Product

Table 89. PanTheryx Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 90. PanTheryx Recent Development

Table 91. Hubei Reborn Biotech Company Details

Table 92. Hubei Reborn Biotech Business Overview

Table 93. Hubei Reborn Biotech Bioactive Protein and Peptides Product

Table 94. Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 95. Hubei Reborn Biotech Recent Development

Table 96. Seagarden Company Details

Table 97. Seagarden Business Overview

Table 98. Seagarden Bioactive Protein and Peptides Product

Table 99. Seagarden Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 100. Seagarden Recent Development

Table 101. Shandong Hengxin Biotech Company Details

Table 102. Shandong Hengxin Biotech Business Overview

Table 103. Shandong Hengxin Biotech Bioactive Protein and Peptides Product

Table 104. Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 105. Shandong Hengxin Biotech Recent Development

Table 106. Baotou Dongbao Bio-Tech Company Details

Table 107. Baotou Dongbao Bio-Tech Business Overview

Table 108. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product

Table 109. Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 110. Baotou Dongbao Bio-Tech Recent Development

Table 111. Wuhan Jiushengtang Biotech Company Details

Table 112. Wuhan Jiushengtang Biotech Business Overview

Table 113. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product

Table 114. Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 115. Wuhan Jiushengtang Biotech Recent Development

Table 116. Morinaga Milk Company Details

Table 117. Morinaga Milk Business Overview

Table 118. Morinaga Milk Bioactive Protein and Peptides Product

Table 119. Morinaga Milk Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 120. Morinaga Milk Recent Development

Table 121. Collagile Company Details

Table 122. Collagile Business Overview

Table 123. Collagile Bioactive Protein and Peptides Product

Table 124. Collagile Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 125. Collagile Recent Development

Table 126. Nuritas Company Details

Table 127. Nuritas Business Overview

Table 128. Nuritas Bioactive Protein and Peptides Product

Table 129. Nuritas Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 130. Nuritas Recent Development

Table 131. SmartPEP Company Details

Table 132. SmartPEP Business Overview

Table 133. SmartPEP Bioactive Protein and Peptides Product

Table 134. SmartPEP Revenue in Bioactive Protein and Peptides Business (US$ Million), 2021–2026

Table 135. SmartPEP Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Bioactive Protein and Peptides Picture

Figure 2. Global Bioactive Protein and Peptides Market Size Comparison by Source (US$ Million), 2021–2032

Figure 3. Global Bioactive Protein and Peptides Market Share by Source: 2025 vs 2032

Figure 4. Plant Source Features

Figure 5. Animal Source Features

Figure 6. Global Bioactive Protein and Peptides Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Bioactive Protein and Peptides Market Share by Application: 2025 vs 2032

Figure 8. Functional Food Case Studies

Figure 9. Dietary Supplements Case Studies

Figure 10. Personal Care Case Studies

Figure 11. Animal Nutrition Case Studies

Figure 12. Other Case Studies

Figure 13. Bioactive Protein and Peptides Report Years Considered

Figure 14. Global Bioactive Protein and Peptides Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Bioactive Protein and Peptides Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Bioactive Protein and Peptides Market Share by Region: 2025 vs 2032

Figure 17. Global Bioactive Protein and Peptides Market Share by Players in 2025

Figure 18. Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2025

Figure 20. North America Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Bioactive Protein and Peptides Market Share by Country (2021–2032)

Figure 22. United States Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Bioactive Protein and Peptides Market Share by Country (2021–2032)

Figure 26. Germany Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Bioactive Protein and Peptides Market Share by Region (2021–2032)

Figure 34. China Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Bioactive Protein and Peptides Market Share by Country (2021–2032)

Figure 42. Mexico Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Bioactive Protein and Peptides Market Share by Country (2021–2032)

Figure 46. Israel Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Bioactive Protein and Peptides Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Gelita Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 50. Kerry Group Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 51. Vital Proteins Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 52. Rousselot Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 53. BRF Ingredients Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 54. Bunge Ltd Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 55. Ingredia Nutritional Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 56. Gelatines Weishardt Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 57. PanTheryx Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 58. Hubei Reborn Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 59. Seagarden Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 60. Shandong Hengxin Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 61. Baotou Dongbao Bio-Tech Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 62. Wuhan Jiushengtang Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 63. Morinaga Milk Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 64. Collagile Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 65. Nuritas Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 66. SmartPEP Revenue Growth Rate in Bioactive Protein and Peptides Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Bioactive Whey Protein Market Research Report 2025

Global Bioactive Peptides in Cosmetics Market Research Report 2024

Global Exogenous Bioactive Peptides Market Research Report 2024

Global Bio Active Protein Market Research Report 2024

Global Endogenous Bioactive Peptides Market Research Report 2024

Global Marine Bioactive Peptides Market Research Report 2024

Global Bioactive Collagen Peptides Market Research Report 2024

Global Physiologically Active Peptides Market Research Report 2024

Bioactive Ingredients Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti aging and Anti wrinkle Products Market Research Report 2024

Global Bio active Peptides Market Research Report 2024

Global Functional Food and Nutraceuticals Market Research Report 2024

Global Peptide APIs Market Insights Forecast to 2030

Global Biologic Peptide API Market Research Report 2024

Plant Based Bioactive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Active Nutraceutical Ingredients Market Research Report 2024

Global Therapeutic Peptide APIs Market Research Report 2024

Food grade Amino Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bioactive Coatings Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions